LMR Partners’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NRIX
BBA
LMR Partners's NRIX Position: Q3 2026 in Review
LMR Partners opened a new position in Nurix Therapeutics (NRIX) in Q3 2026: 131,011 shares worth $3.11M. The stake represents 0.01% of the portfolio and ranks #828 among its holdings.
234 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.
- LMR Partners held 131,011 shares of Nurix Therapeutics worth $3.11M as of Q3 2026.
- Nurix Therapeutics was a new LMR Partners position in Q3 2026.
- Nurix Therapeutics made up 0.01% of LMR Partners's portfolio in Q3 2026, its #828 holding.
- 234 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.